Inventor · disambiguated record
Xiao Yu
Also filed as: YU XIAO · YU XIAO-MING
6 granted patents·6 pending applications·144 citations·filing 2005–2024
82Inventor score
Files withXENAMED CORP7UNIV KANSAS2CELISTA PHARMACEUTICALS LLC1FARSIGHT MEDICAL TECH SHANGHAI CO LTD1UNIV HONG KONG SCIENCE & TECHN1
Top patents by PatentIndex Score
12 records- 0196US7608594B2Novobiocin analogues as anticancer agentsUNIV KANSAS·Filed 2005·Granted Oct 27, 2009·108 cites·34 claims
- 0293US7811998B2Novobiocin analogues as anticancer agentsUNIV KANSAS·Filed 2009·Granted Oct 12, 2010·30 cites·18 claims
- 0385US11975103B2Compositions of midodrine and methods of using the sameXENAMED CORP·Filed 2021·Granted May 7, 2024·1 cites·20 claims
- 0485US11202760B2Compositions of midodrine and methods of using the sameXENAMED CORP·Filed 2017·Granted Dec 21, 2021·3 cites·20 claims
- 0577US12213953B2Extended release midodrine hydrochloride compositions and methods of useXENAMED CORP·Filed 2018·Granted Feb 4, 2025·1 cites·18 claims
- 0675US2025120919A1Compositions of midodrine and methods of using the sameXENAMED CORP·Filed 2024·Application pending·0 cites
- 0772US2025228802A1Extended release midodrine hydrochloride compositions and methods of useXENAMED CORP·Filed 2024·Application pending·0 cites
- 0871US2025108026A1Droxidopa compositions and methodsXENAMED CORP·Filed 2024·Application pending·0 cites
- 0961US7652136B2Diarylaminofluorene-based organometallic phosphors and organic light-emitting devices made with such compoundsUNIV HONG KONG SCIENCE & TECHN·Filed 2006·Granted Jan 26, 2010·1 cites·19 claims
- 1056US2023174583A1Preparation of cyclosporin derivativesFARSIGHT MEDICAL TECH SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 1146US2021128549A1Oxycodone and methylnaltrexone multiparticulates and suspensions containing themCELISTA PHARMACEUTICALS LLC·Filed 2019·Application pending·0 cites
- 1245US2019321318A1Droxidopa compositions and methodsXENAMED CORP·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →